NEW YORK (GenomeWeb News) - Tm Bioscience today said two labs in Ontario are using its ID-TAG Respiratory Viral Panel to detect acute respiratory pathogens.
The company said St. Joseph's Healthcare in Hamilton, Ontario, and London Health Sciences Center, in London, Ontario, are using its RVP, which is designed to detect "the majority of strains and subtypes of respiratory viruses" including those that cause influenza strains A and B.
Tm Bio's president and CEO, Greg Hines, said the deals reflect "the growing recognition of the value of our approach to infectious disease testing."
Jim Mahony, a lab director at St. Joseph's, said the RVP test "rapidly detects and identifies specific pathogens from a long list of potential respiratory viruses," which doctors can use to determine treatment methods.
Financial terms of the agreements were not disclosed.